BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 35842659)

  • 1. The associations between serum high-density lipoprotein cholesterol levels and malignant behavior in pancreatic neuroendocrine neoplasms.
    Quan L; Liu Y; Cui W; Wang X; Zhang W; Wang Z; Guo C; Lu C; Hu F; Chen X
    Lipids Health Dis; 2022 Jul; 21(1):58. PubMed ID: 35842659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The association between pain and WHO grade of pancreatic neuroendocrine neoplasms: A multicenter study.
    Wang C; Lin T; Chen X; Cui W; Guo C; Wang Z; Chen X
    Cancer Biomark; 2023; 36(4):279-286. PubMed ID: 36938727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The association between non-HDL cholesterol and high-grade pancreatic neuroendocrine neoplasms.
    Zhou H; Zhu Y; Qin B; Liu Y; Wang Z; Guo C; Wang J; Chen X
    Endocrine; 2024 Jun; ():. PubMed ID: 38844608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The association between jaundice and poorly differentiated pancreatic neuroendocrine neoplasms (Ki67 index > 55.0%).
    Liu Y; Wang J; Zhou H; Wei Z; Wang J; Wang Z; Chen X
    BMC Gastroenterol; 2023 Dec; 23(1):436. PubMed ID: 38087239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD56 Expression Is Associated with Biological Behavior of Pancreatic Neuroendocrine Neoplasms.
    Chen X; Guo C; Cui W; Sun K; Wang Z; Chen X
    Cancer Manag Res; 2020; 12():4625-4631. PubMed ID: 32606955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Textural analysis on contrast-enhanced CT in pancreatic neuroendocrine neoplasms: association with WHO grade.
    Guo C; Zhuge X; Wang Z; Wang Q; Sun K; Feng Z; Chen X
    Abdom Radiol (NY); 2019 Feb; 44(2):576-585. PubMed ID: 30182253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of 100 consecutive cases of resectable pancreatic neuroendocrine neoplasms: clinicopathological characteristics and long-term outcomes.
    Cheng Y; Zhan H; Wang L; Xu J; Zhang G; Zhang Z; Hu S
    Front Med; 2016 Dec; 10(4):444-450. PubMed ID: 27757796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A systematic review and meta-analysis of the clinicopathologic characteristics of cystic versus solid pancreatic neuroendocrine neoplasms.
    Koh YX; Chok AY; Zheng HL; Tan CS; Goh BK
    Surgery; 2014 Jul; 156(1):83-96.e2. PubMed ID: 24878455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroendocrine Tumor Heterogeneity Adds Uncertainty to the World Health Organization 2010 Classification: Real-World Data from the Spanish Tumor Registry (R-GETNE).
    Nuñez-Valdovinos B; Carmona-Bayonas A; Jimenez-Fonseca P; Capdevila J; Castaño-Pascual Á; Benavent M; Pi Barrio JJ; Teule A; Alonso V; Custodio A; Marazuela M; Segura Á; Beguiristain A; Llanos M; Martinez Del Prado MP; Diaz-Perez JA; Castellano D; Sevilla I; Lopez C; Alonso T; Garcia-Carbonero R
    Oncologist; 2018 Apr; 23(4):422-432. PubMed ID: 29330208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. APOBEC3B High Expression in Gastroenteropancreatic Neuroendocrine Neoplasms and Association With Lymph Metastasis.
    Feng C; Zheng Q; Yang Y; Xu M; Lian Y; Huang J; Jiang Y
    Appl Immunohistochem Mol Morphol; 2019 Sep; 27(8):599-605. PubMed ID: 30095460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of morphological features in lymph node metastasis between pancreatic neuroendocrine neoplasms and pancreatic ductal adenocarcinomas.
    Takahashi D; Kojima M; Morisue R; Sugimoto M; Kobayashi S; Takahashi S; Konishi M; Gotohda N; Ikeda M; Ochiai A
    Pancreatology; 2020 Jul; 20(5):936-943. PubMed ID: 32553561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Malignant potential of small pancreatic neuroendocrine neoplasm and its risk factors: A multicenter nationwide study.
    Paik WH; Lee HS; Lee KJ; Jang SI; Lee WJ; Hwang JH; Cho CM; Park CH; Han J; Woo SM; Jeong S; Chon HK; Kim TN; Lee JK; Han JH; Yoon JH; Kim YT; Cho JH
    Pancreatology; 2021 Jan; 21(1):208-214. PubMed ID: 33281058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical relevance of different WHO grade 3 pancreatic neuroendocrine neoplasms based on morphology.
    Han X; Xu X; Ma H; Ji Y; Wang D; Kuang T; Wu W; Song B; Li G; Jin G; Lou W
    Endocr Connect; 2018 Feb; 7(2):355-363. PubMed ID: 29472376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive value of preoperative peripheral blood neutrophil/lymphocyte ratio for lymph node metastasis in patients of resectable pancreatic neuroendocrine tumors: a nomogram-based study.
    Tong Z; Liu L; Zheng Y; Jiang W; Zhao P; Fang W; Wang W
    World J Surg Oncol; 2017 May; 15(1):108. PubMed ID: 28558772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diabetes in Patients With Pancreatic Neuroendocrine Neoplasms.
    Zhuge X; Wang Y; Chen X; Guo C
    Front Endocrinol (Lausanne); 2020; 11():615082. PubMed ID: 33424776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between radiologic features on contrast-enhanced CT and pathological tumor grades in pancreatic neuroendocrine neoplasms.
    Xu W; Yan H; Xu L; Li M; Gao W; Jiang K; Wu J; Miao Y
    J Biomed Res; 2020 Aug; 35(3):179-188. PubMed ID: 33637654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of prognosis between observation and surgical resection groups with small sporadic non-functional pancreatic neuroendocrine neoplasms without distant metastasis.
    Kurita Y; Hara K; Kuwahara T; Mizuno N; Okuno N; Haba S; Okuno M; Natsume S; Senda Y; Kubota K; Nakajima A; Niwa Y; Shimizu Y
    J Gastroenterol; 2020 May; 55(5):543-552. PubMed ID: 31858231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Morphological and immunohistochemical profile of pancreatic neuroendocrine neoplasms.
    Simtniece Z; Vanags A; Strumfa I; Sperga M; Vasko E; Prieditis P; Trapencieris P; Gardovskis J
    Pol J Pathol; 2015 Jun; 66(2):176-94. PubMed ID: 26247532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An miRNA Signature Predicts Grading of Pancreatic Neuroendocrine Neoplasms.
    Saller J; White D; Hough B; Yoder S; Whiting J; Chen DT; Magliocco A; Coppola D
    Cancer Genomics Proteomics; 2023; 20(2):154-164. PubMed ID: 36870693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The high-grade (WHO G3) pancreatic neuroendocrine tumor category is morphologically and biologically heterogenous and includes both well differentiated and poorly differentiated neoplasms.
    Basturk O; Yang Z; Tang LH; Hruban RH; Adsay V; McCall CM; Krasinskas AM; Jang KT; Frankel WL; Balci S; Sigel C; Klimstra DS
    Am J Surg Pathol; 2015 May; 39(5):683-90. PubMed ID: 25723112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.